Acticor Biotech’s IPO

McDermott has advised Acticor Biotech on the offering. Acticor Biotech, a clinical stage biopharmaceutical company dedicated to developing a drug for the treatment of cardiovascular emergencies,...

This content is for Standard 1 Year members only.
Login Join Now